Patron-in-Chief, Victorian Governor, the Honourable Linda Dessau AC.

News & Events Donate Now

Support women in science at Burnet Institute

Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.

Support women in science at Burnet Institute

Support Us

  • Donate Now
  • Where the need is greatest.
  • Bequests and Gifts in Wills
  • Support women in science at Burnet Institute
  • Support Burnet’s COVID-19 response
  • Healthy Mothers, Healthy Babies: Research to Save Lives
  • Help save the lives of mums and babies in PNG
  • Join the fight to achieve global malaria elimination targets

View us on Facebook View us on Twitter View us on LinkedIn View us on Instagram

Burnet Institute: Medical Research. Practical Action.

A more equitable world through better health.


About

About

Our History
  • Overview
  • Leadership Team
  • Burnet 2030
  • Patrons & Ambassadors
  • Policies
  • Annual & Financial Reports
  • Publications & Reports
  • Gender Equity
  • Reconciliation
  • Trusts and Foundations
  • Where We Work
  • History
  • Contact Us
People

People

Working Groups
  • Leadership Team
  • Working Groups
  • Staff & Students
  • Careers
Research

Research

Disease Elimination
  • Programs
  • Flagship Initiatives
  • Technical Breadth
  • Research Themes
  • Research Translation
  • Facilities
  • Peer-reviewed Publications
  • People
  • Disease Elimination
  • Health Security and Pandemic Preparedness
  • Maternal, Child and Adolescent Health
  • Burnet Diagnostics Initiative (BDI)
  • Know-C19
  • EC Australia
  • Healthy Mothers, Healthy Babies (HMHB)
  • Vaccines
  • Diagnostics
  • Modelling
COVID-19

COVID-19

Know-C19 Hub
  • Know-C19 Hub
  • The Optimise Study
  • Vaccine Development
  • Diagnostic Development
  • COVID-19 Modelling
  • COVID-19 Research Reports
  • Burnet and COVID-19: Impact and Timeline
  • How Science Matters podcast
  • Support our COVID-19 work
Changing Lives

Changing Lives

Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.

  • IMPACT Magazine
  • How Science Matters podcast
  • Where we work
Opportunities

Opportunities

Collaborate and partner with us
  • Careers – work with us
  • Education – study with us
  • Collaborate and partner – research opportunities
  • Stellabody®
Support Us

Support Us

Donate today and help reduce the rate of stillbirth in India and around the globe.
  • Latest Appeal
  • Trusts and Foundations
  • Research Action Partner
  • Workplace Giving
  • Giving Stories
  • Donate Now
  • Bequests and Gifts in Wills
Burnet Institute Donate Now
News & Events
News & EventsNewsEventsPublications & ReportsSubscribe
About
AboutOverviewLeadership TeamBurnet 2030Patrons & AmbassadorsPoliciesAnnual & Financial ReportsPublications & ReportsGender EquityReconciliationTrusts and FoundationsWhere We WorkHistoryContact Us
People
PeopleLeadership TeamWorking GroupsStaff & StudentsCareers
Research
Programs
Disease EliminationHealth Security and Pandemic PreparednessMaternal, Child and Adolescent Health
Flagship Initiatives
Burnet Diagnostics Initiative (BDI)Know-C19EC AustraliaHealthy Mothers, Healthy Babies (HMHB)
Technical Breadth
VaccinesDiagnosticsModelling
Research ThemesResearch TranslationFacilitiesPeer-reviewed PublicationsPeople
COVID-19
COVID-19Know-C19 HubThe Optimise StudyVaccine DevelopmentDiagnostic DevelopmentCOVID-19 ModellingCOVID-19 Research ReportsBurnet and COVID-19: Impact and TimelineHow Science Matters podcastSupport our COVID-19 work
Changing Lives
IMPACT MagazineHow Science Matters podcastWhere we work
Opportunities
Careers – work with usEducation – study with usCollaborate and partner – research opportunitiesStellabody®
Support Us
Support UsLatest AppealTrusts and FoundationsResearch Action PartnerWorkplace GivingGiving StoriesDonate NowBequests and Gifts in Wills

  • Alcohol and Other Drugs Group

    Co-Heads: Professor Paul Dietze and Associate Professor Peter Higgs

    Alcohol and other drugs are a major issue in Australia and Burnet has an established reputation in working to alleviate harms associated with their use.

  • Burnet Diagnostics Initiative (BDI)

    Director: Jennifer Barnes; Scientific Director: Professor Heidi Drummer

    BDI is a commitment by Burnet Institute to develop the systems, resources, and processes to support diagnostics product development and enhance translation of its point-of-care diagnostics research into practical health solutions.

  • Diagnostic Markers in Chronic Immune Disorders Group

    Head: Dr Raffi Gugasyan

    Understanding the role of key signalling molecules that are critical for the normal development and function of T and B lymphocytes.

  • Global Adolescent Health Group

    Head: Dr Elissa Kennedy

    Adolescence as a key developmental stage within the life-course, where investments bring a triple dividend of benefits – now, into future adult life, and for the next generation of children.

  • Global Health: policy, practice and community action

    Co-Heads: Lisa Davidson and Chad Hughes.

    Translating research into sustainable health solutions for vulnerable communities through health system strengthening, improved health service delivery and empowering communities.

  • Global Women's and Newborn's Health Group

    Co-Heads: Professor Caroline Homer AO and Associate Professor Joshua Vogel

    Improving health outcomes for at-risk mothers and newborn babies.

  • HIV Prevention Group

    Head: Professor Mark Stoové

    Conducts innovative research aimed at understanding the transmission and prevention of HIV.

  • HIV, inflammation and the microbiome

    Head: Dr Lindi Masson

    Identifying risk factors for HIV acquisition in young South African women and developing strategies to reduce this risk.

  • Immune Therapies Group

    Head: Professor Mark Hogarth

    Creating powerful antibody-based biological drugs which will form the basis of next generation therapeutics.

  • Infection, Inflammation, and Innate Immunity Group

    Head: Dr Anna Hearps

    Develop prognostic tools and adjunctive therapies to predict and improve health outcomes for HIV patients.

  • Infectious Diseases Systems Epidemiology Group

    Head: Professor Alyssa Barry

    Humans and pathogens exist in complex populations and environments, which impacts disease transmission and risk, prevention, treatment and public health responses.

  • Justice Health Group

    Co-Heads: Professor Mark Stoové, Doctor Rebecca Winter

    Undertakes research to build the evidence base for policy and practice to improve outcomes for prisoners and ex-prisoners.

  • Malaria and Infectious Diseases Epidemiology Group

    Head: Professor Freya Fowkes

    Understanding malaria dynamics in populations is key to implementing effective public health control measures.

  • Malaria Immunity and Vaccines Group

    Head: Professor James Beeson

    Research focussed on immunity, vaccines, new treatments and clinical studies of malaria.

  • Malaria Virulence and Drug Discovery Group

    Co-Heads: Dr Paul Gilson and Professor Brendan Crabb AC

    Malaria is a devastating parasitic disease that is becoming resistant to current medicines so new treatments need to be developed for future use.

  • Modelling and Biostatistics Group

    Head: Dr Nick Scott

    Modelling plays a critical role in translating data into decision-making evidence.

  • Retroviral Biology and Antivirals Group

    Head: Professor Gilda Tachedjian

    Discovery of new drug targets for antiretroviral therapy and prevention.

  • Surveillance and Evaluation Group

    Head: Professor Margaret Hellard; Manager: Jason Asselin

    This group manages HIV, Viral Hepatitis and STIs surveillance systems and conducts evaluations of projects and programs.

  • Tuberculosis Elimination and Implementation Science Group

    Co-Head: Dr Philipp du Cros; Acting Co-Head: Dr Khai Lin Huang

    Supporting national tuberculosis programs in the Asia-Pacific region to address drug-resistant tuberculosis.

  • Vector-Borne Diseases and Tropical Public Health Group

    Head: Professor Leanne Robinson

    Accelerating towards elimination of vector-borne diseases such as malaria and lymphatic filariasis requires new approaches to diagnosis, surveillance and intervention.

  • Viral Entry and Vaccines Group

    Co-Heads: Professor Heidi Drummer and Doctor Andy Poumbourios

    Examining how HIV and hepatitis C virus attach to and enter cells.

  • Viral Hepatitis Elimination Group

    Co-Heads: Professor Margaret Hellard and Associate Professor Joseph Doyle

    Improving the understanding of hepatitis C and its transmission, and the management and care of people already infected with these viruses.

  • Young People's Health Group

    Head: Associate Professor Megan Lim

    Examines the epidemiology and consequences of risk behaviours among young people.


  • Home

Our purpose:

To create and translate knowledge into better health, so no-one is left behind.

Contact Us

85 Commercial Road, Melbourne
VIC, 3004, Australia

  • E: reception@burnet.edu.au
  • T: +61 3 9282 2111

Subscribe

Receive updates and IMPACT magazine.

The Hub Site Map Careers
Disclaimer Privacy Policy Complaints Policy

Copyright © 2023 Burnet Institute. ABN: 49 007 349 984

This website was developed with the generous support of a donor.

Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.

Oops!

It looks like something may have gone wrong, and some of the resources required to load the page may not have loaded correctly.

The page may continue to work, but for the best experience we recommend that you refresh your browser.
If this problem persists, please call us on +61 3 9282 2111 or email us.

Try again Continue anyway